Latent Labs Technologies operates as a frontier artificial intelligence laboratory that builds generative models for molecular biology. The company provides AI-driven tools and agents—such as Latent-Y, Latent-X2, and Latent-X—to help researchers and partners design drugs, create antibodies, optimize enzymes, and advance genetic engineering.
Subscribe to see Latent Labs Technologies, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Latent Labs Technologies, Inc. is an artificial intelligence & biotechnology company headquartered in United States. It has raised at least $49M across the 2 funding rounds on record. Its most recent funding round raised $39.9M in December 2024. Xcout tracks 5 named people at Latent Labs Technologies, Inc., including Simon Kohl (Chief Executive Officer).
At least $49M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $39.9M | — | |
| SEC Form D filing | $9.1M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Latent Labs Technologies, Inc.'s closest competitors — see the full list of competitors and alternatives →
Astromech AI Corp. is developing an autonomous biological intelligence system, termed the Large Life Model, which integrates deep learning with evolutionary biology. The platform is designed to process multi-species transcriptomic and genomic data to assist researchers in therapeutic development, trait optimization, and systems biology.
Anto Biosciences is a frontier biology AI lab founded in 2025 and headquartered in San Francisco, California, building multimodal foundation models to make the gut microbiome computable.
DenovAI Biotech Ltd is an Israeli biotechnology startup founded in 2023 and operated through the AION Labs venture studio in Rehovot. The company develops a generative AI and physics platform focused on the de novo design of novel proteins and therapeutic biologics.
Pepticom operates an artificial intelligence-driven drug discovery platform focused on designing and optimizing novel therapeutic peptides. The company utilizes reinforcement learning, generative AI, and computational algorithms to develop drug candidates for both internal programs and industry collaborations.
TenAces Biosciences is an Israel-based biopharmaceutical company and AION Labs startup that develops molecular glue therapeutics. The company utilizes machine learning and an AI platform to identify protein interactions and discover new molecular glue therapies.
PostEra is an AI-first biotechnology company utilizing its proprietary Proton platform for medicinal chemistry to discover and develop new medicines for patients. The company operates out of Boston and Cambridge, Massachusetts.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about Latent Labs Technologies, Inc.? Suggest a correction · Work at Latent Labs Technologies, Inc.? Claim this profile
Post the link and the card appears automatically — each network fetches the image itself.